Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Johan Malm. (2004) Therapeutic thyroid hormone ligand patents 1998 – 2003. Expert Opinion on Therapeutic Patents 14:8, pages 1169-1183.
Read now
Read now
Terry Jones. (2001) The effect of HMG-CoA reductase inhibitors on chronic allograft rejection. Emerging Drugs 6:1, pages 95-109.
Read now
Read now
David A Perry. (2000) Patent focus on agents for atherosclerosis: September 1999 - February 2000. Expert Opinion on Therapeutic Patents 10:5, pages 549-557.
Read now
Read now
Kenneth L Clark & Linda Merkel. (2000) Potential of adenosine receptor agonists for the prevention and treatment of coronary artery disease and acute myocardial infarction. Emerging Drugs 5:1, pages 89-108.
Read now
Read now
Articles from other publishers (15)
H. James HarwoodJr.Jr., Paul Listrani & Janice D. Wagner. (2012) Nonhuman Primates and other Animal Models in Diabetes Research. Journal of Diabetes Science and Technology 6:3, pages 503-514.
Crossref
Crossref
Janice D. Wagner, Jennifer A. Cann, Li Zhang & H. James HarwoodJr.Jr.. 2012. Nonhuman Primates in Biomedical Research. Nonhuman Primates in Biomedical Research
699
732
.
Donald J. AbrahamJohan Malm & Gary J. Grover. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
189
238
.
Janice D. Wagner, Melanie K. Shadoan, Li Zhang, Gina M. Ward, Lori J. Royer, Kylie Kavanagh, Omar L. Francone, Bruce J. Auerbach & H. James HarwoodJr.Jr.. (2010) A Selective Peroxisome Proliferator-Activated Receptor α Agonist, CP-900691, Improves Plasma Lipids, Lipoproteins, and Glycemic Control in Diabetic Monkeys. Journal of Pharmacology and Experimental Therapeutics 333:3, pages 844-853.
Crossref
Crossref
Bruce A. Hay, Barbara Abrams, Allice Y. Zumbrunn, James J. Valentine, Laurie C. Warren, Stephen F. Petras, Lorraine D. Shelly, Angela Xia, Alison H. Varghese, Julie L. Hawkins, Jennifer A. Van Camp, Michael D. Robbins, Katherine Landschulz & H. James HarwoodJr.Jr.. (2007) Aminopyrrolidineamide inhibitors of site-1 protease. Bioorganic & Medicinal Chemistry Letters 17:16, pages 4411-4414.
Crossref
Crossref
Sean Ekins, Dayna C. Mankowski, Dennis J. Hoover, Michael P. Lawton, Judith L. Treadway & H. James HarwoodJr.Jr.. (2007) Three-Dimensional Quantitative Structure-Activity Relationship Analysis of Human CYP51 Inhibitors. Drug Metabolism and Disposition 35:3, pages 493-500.
Crossref
Crossref
Bharti Shah, Shashank Rohatagi, Chandrasekhar Natarajan, Stephane Kirkesseli, Robert Baybutt & Bradford K. Jensen. (2004) Pharmacokinetics, Pharmacodynamics, and Safety of a Lipid-Lowering Adenosine A1 Agonist, RPR749, in Healthy Subjects. American Journal of Therapeutics 11:3, pages 175-189.
Crossref
Crossref
Charles E. Chandler, Donald E. Wilder, Judith L. Pettini, Yvette E. Savoy, Stephen F. Petras, George Chang, John Vincent & H. James HarwoodJr.Jr.. (2003) CP-346086. Journal of Lipid Research 44:10, pages 1887-1901.
Crossref
Crossref
Donald J. AbrahamDenis E. Ryono, Gary J. Grover & Karin Mellstrom. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
563
592
.
Donald J. AbrahamMichael L. Sierra. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
339
383
.
Lucio Toma, Maria Paola Giovannoni, Vittorio Dal Piaz, Byoung-Mog Kwon, Young-Kook Kim, Arianna Gelain & Daniela Barlocco. (2002) Mono- and Di-substituted 5,6-Diphenyl-3-alkylaminopyridazines Active as ACAT Inhibitors. HETEROCYCLES 57:1, pages 39.
Crossref
Crossref
D Junquero, F Bruniquel, X N'Guyen, J.-M Autin, J.-F Patoiseau, A.-D Degryse, F.C Colpaert & A Delhon. (2001) F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet. Atherosclerosis 155:1, pages 131-142.
Crossref
Crossref
Didier Junquero, Antoine Pilon, Elizabeth Carilla-Durand, Jean-François Patoiseau, Jean-Pierre Tarayre, Gérard Torpier, Bart Staels, Jean-Charles Fruchart, Françis C. Colpaert, Véronique Clavey & André Delhon. (2001) Lack of toxic effects of F 12511, a novel potent inhibitor of acyl-coenzyme A: cholesterol O-acyltransferase, on human adrenocortical cells in culture11Abbreviations: ACAT, acyl-coenzyme A: cholesterol O-acyltransferase; F 12511, (S)-2′,3′,5′-trimethyl-4′-hydroxy-α-dodecylthio-phenylacetanilide; DMEM, Dulbecco’s modified Eagle medium; FBS, fetal bovine serum; LDL, low-density lipoprotein; HDL, high-density lipoprotein; SR-BI, scavenger receptor class B, type I; P450scc, cytochrome P450 cholesterol side-chain cleavage; P450c17, cytochrome P450 17 α-hydroxylase; P450c21, cytochrome P450 21-hydroxylase; PMA, phorbol 12-myristate 13-acetate; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; cAMP, adenosine 3′5′-cyclic monophosphate; ITS, insulin-transferrin-linoleic acid; and MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.. Biochemical Pharmacology 61:4, pages 387-398.
Crossref
Crossref
Xiaojing Yang, Leanne Buzon, Ernie Hamanaka & Kevin K.-C. Liu. (2000) Enzymatic resolution of benzothiazepine for the preparation of squalene synthetase inhibitors. Tetrahedron: Asymmetry 11:22, pages 4447-4450.
Crossref
Crossref
Drago R. Sliskovic, Brian R. Krause & Thomas M.A. Bocan. 1999.
101
110
.